newsfilter
← Latest News
ACCESS Newswire·

CureVac Announces Solid Progress in Phase 2 COVID-19 and Seasonal Flu Clinical Development Programs in Collaboration with GSK

COVID-19 Phase 2 clinical trial fully enrolledStudy compares mono- and bivalent vaccine candidates against licensed comparator COVID-19 vaccineFirst participant dosed in seasonal flu Phase 2 part of combined Phase 1/2